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Available online xxxxThis study aimed to explore the possible independent associations of sedentary behaviour (SB), physical activity
(PA), and cardiorespiratory fitness (CRF) with clustered (CCRS) and individual cardiometabolic risk (waist cir-
cumference [waist], systolic/diastolic blood pressure, triglycerides, high-density lipoprotein-cholesterol, and
fasting blood glucose) in patients with psychosis. In 43 outpatients with psychosis (mean age ± SD: 42.3 ±
8.5 years, 86% men), SB and light, moderate-to-vigorous, and total PA were measured with the SenseWear
Pro3 Armband, and CRF with the 6-minute walking test. Multiple linear regression models adjusted for
multiple confounders were applied. High SB, low PA and low CRF levels were associated with an unfavourable
cardiometabolic risk profile (increased presence of metabolic syndrome and number of cardiometabolic abnor-
malities, as well as worse values and elevated presence of abnormalities for all individual cardiometabolic risk
factors). SBwas associatedwith CCRS, number of cardiometabolic abnormalities, waist, and fasting blood glucose
(all p b 0.05). After adjusting for PA and CRF, waist and fasting blood glucose remained significant. Light PA was
associatedwithwaist, moderate-to-vigorous PAwith CCRS, and total PAwith CCRS andwaist (all p b 0.05). These
results became non-significant after adjusting for SB and CRF. CRF was associated with CCRS, waist, and systolic
blood pressure (all p b 0.05). The associationswith CCRS andwaist remained significant after adjusting for SB and
PA. Together, these results suggest the importance of considering SB and CRF, regardless PA, in the prevention
and treatment of cardiometabolic disorders among patients with psychosis.






Patients with psychosis, including schizophrenia and bipolar disor-
ders (World Health Organization, 1992), have a greatly reduced life ex-
pectancy, up to 15 years, compared to the general population (Lawrence
et al., 2013), with cardiometabolic disease being the main contributor
(Correll et al., 2017). The increased prevalence of metabolic syndrome
and cardiometabolic abnormalities is also evident (Vancampfort et al.,
2015b), and has become a major health challenge. Of concern, a recent
study (Bruins et al., 2017) revealed that cardiometabolic risk factors re-
main seriously undertreated in people with psychosis and, therefore,
better prevention and treatment of metabolic disorders are imperative
for reducing the overwhelming risk of premature mortality.
In general population, there is an established-evidence base indicat-
ing that, independently, less sedentary behaviour (SB) and greater
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hr. Res. (2017), https://doi.or2015). Two meta-analyses (Stubbs et al., 2016a; Stubbs et al., 2016b)
highlighted that patients with psychosis engage in more SB and in less
PA than the general population. To date, some studies (e.g., (Nyboe
et al., 2015; Stubbs et al., 2015; Vancampfort et al., 2015a)) have sug-
gested associations of SB and PA with cardiometabolic risk in patients
with psychosis. While helpful, almost all of these studies have relied
upon self-report measures, which introduce bias (Soundy et al., 2014),
and only one study examined the independent associations of SB and
PA with cardiometabolic risk (Stubbs et al., 2017). In this regard, more
research, as well as the preferential use of objective measures, is neces-
sary to improve our understanding of the independent effects of these
two exposures on cardiometabolic health in this population.
There is also a firmly established-base indicating that a low cardiore-
spiratory fitness (CRF) level is a strong independent predictor of all-
cause and cardiovascular mortality (Harber et al., 2017), with two re-
cent studies (Knaeps et al., 2016a; Knaeps et al., 2016b) finding that
CRF mediates the association of SB and PA with clustered-
cardiometabolic risk and its individual-components. Patients with
psychosis have significantly lower CRF compared with controls
(Vancampfort et al., 2017), and the independent associations of SB,
PA, and CRF with clustered-cardiometabolic risk and individual-
cardiometabolic risk factors remain unexplored.physical activity, cardiorespiratory fitness and cardiometabolic risk in
g/10.1016/j.schres.2017.10.012
2 J. Bueno-Antequera et al. / Schizophrenia Research xxx (2017) xxx–xxxThe aim of this study was to explore the possible independent asso-
ciations of SB, PA, and CRF with clustered-cardiometabolic risk and
individual-cardiometabolic risk factors in patients with psychosis
(schizophrenia and bipolar disorders).
2. Methods
2.1. Participants and setting
Adults with a diagnosis of psychotic illness including schizophrenia
and bipolar disorders according to ICD-10 criteria and stabilized on an-
tipsychotic medication was recruited from 11 different outpatient
mental healthcare settings in southern Spain. Patients were excluded
if they had clinical instability, co-morbid substance abuse, or evidence
of uncontrolled cardiovascular, neuromuscular and endocrinedisorders.
Participants received a full-fasting laboratory screening and anthropo-
metric measurement, performed a walk test, wore a multisensor
armband, and completed questionnaires about sociodemographic char-
acteristics and symptomatology. Patient's medical records were also
registered. The study procedure was approved by the Universidad
Pablo de Olavide Ethics Committee. All patients gave their informed
written consent prior to enrolling in the study and after receiving infor-
mation about the aims and protocol. There was no compensation for
participation.
2.2. SB and PA
SB and PA were obtained with a SenseWear Pro3 Armband
(BodyMedia Inc., Pittsburgh, PA, USA), a device to accurately estimate
energy expenditure (Johannsen et al., 2010). Patients were required to
wear the SenseWear on their left arm triceps muscle for nine consecu-
tive days, 24 h/day, except when showering or swimming. The first
and last days were excluded from the analysis to minimize the Haw-
thorne effect (i.e., “a general scientific fact that the process of observa-
tion alters the phenomenon being observed”) (Corder et al., 2008).
Seven days of recordings with a minimum of 1368 min of registration
per day was necessary to be included in the analysis. Energy expendi-
ture was estimated using data recorded from multiple sensors and
using specific-algorithms developed by the manufacturer (SenseWear
Professional software, version 8.1). Time spent in SB (1.0 b MET ≤ 1.5)
and PA intensities (light, 1.5 b MET ≤ 3.0; moderate-to-vigorous, N3.0
MET; and total N1.5 MET) was derived using the measured MET values
during waking hours.
2.3. CRF
CRF was assessed using the 6-minute walking test according to Rikli
and Jones (1999) in an indoor course with a flat, firm surface and with
minimal external stimuli. Patients were instructed to walk as far as pos-
sible during a 6-minute period around a 45.7-meter rectangular course
delimited by cones, without running or jogging. Resting was allowed if
necessary, but walking was to be resumed as soon as possible.
Standardized-encouragements were used at recommended intervals
(Rikli and Jones, 1999). The same trained instructor explained the pro-
tocol, gave a demonstration prior to the start, supervised the test and re-
corded the total distance walked to the nearest 0.1 m for each patient.
The 6-minute walking test has been shown to be a reliable and valid
method to assess CRF in patients with psychosis (Gomes et al., 2016).
2.4. Cardiometabolic risk
The cardiometabolic risk factors were collected by trained-staff in
the morning after an overnight fast including waist circumference
(waist), systolic/diastolic blood pressure, triglycerides, high-density
lipoprotein-cholesterol, and fasting blood glucose. Waist was
measured to the nearest 0.1 cm using a measuring tape (HarpendenPlease cite this article as: Bueno-Antequera, J., et al., Sedentary behaviour,
psychosis: The PsychiActive project, Schizophr. Res. (2017), https://doi.orAnthropometric Tape; Holtain, Dyfed, UK) placed at the midpoint be-
tween the last rib and the iliac crest. Blood pressure was measured in
a seated position after 10-minute rest periodwith an electronicmonitor
(Omron Healthcare Europe BV, Hoofddorp, The Netherlands) placed on
the left armwrist. Themean of the twomeasures was used for analysis.
If the two measures differed by N1% for waist, N20 mm Hg for systolic
and N10 mm Hg for diastolic blood pressure, a third measure was
taken, and the median of the three was used for analysis (Ward and
Anderson, 1998). The presence ofmetabolic syndrome and cardiometa-
bolic abnormalities was assessed using the International Diabetes
Federation criteria (Alberti et al., 2006). Additionally, a clustered-
cardiometabolic risk score (CCRS) was constructed. The standardized-
normalized indexes (z-score = [value − mean] / standard deviation)
for blood pressure ([systolic + diastolic blood pressure] / 2), triglycer-
ides, fasting blood glucose, waist, and the inverse of high-density lipo-
protein cholesterol were summarized and divided by the number of
variables included (x= 5) to generate the CCRS. Scores above zero rep-
resent higher cardiometabolic risk.
2.5. Severity of psychiatric symptoms
Severity of psychiatric symptoms during the previous week was
assessed using the Brief Symptoms Inventory-18 (Derogatis, 2001),
which has been recommended in patients with mental illness (Prinz
et al., 2013). Scores range 0–72, with higher scores indicating a higher
severity.
2.6. Demographic, illness-related, and medication data
Marital, educational, occupational and smoking status were self-
reported. Weight and height were measured with to the nearest
0.1 kg and 0.1 cm using a scale (TANITA BC-420; Tanita, Tokyo, Japan)
and stadiometer, respectively, and body mass index was calculated.
Age, diagnosis, illness duration, and medication were retrieved from
the patients' medical records, and antipsychotic medication was con-
verted into daily equivalent dosages of chlorpromazine (Gardner et al.,
2010).
2.7. Statistical analysis
Due to the skewed distributions, the analyses included the logarith-
mically transformed data ofmoderate-to-vigorous PA, triglycerides, and
illness duration, as well as the reciprocally transformed data of fasting
blood glucose and the square root-transformed data of chlorpromazine
and severity of psychiatric symptoms. Differences in SB, PA, and CRF be-
tweenmetabolic syndrome presence were tested using Student's t-test.
Patients were divided into groups according to high or low levels of SB,
PA (light, moderate-to-vigorous and total), and CRF using the median
splits, while Student's t, Chi-square, and Fisher exact tests were applied
to establish differences. Pearson correlation coefficients were calculated
between SB, PA, CRF, and cardiometabolic risk. Multiple linear regres-
sion analyses were performed with the cardiometabolic risk outcomes
as dependent variables and SB, PA, and CRF as the independent vari-
ables. Model-1 was adjusted for gender, age, smoking, education, sever-
ity of psychiatric symptoms, illness duration, and chlorpromazine dose.
Waist was added in Model-2. Additionally, SB, PA, and CRF, as applica-
ble, were added in the fully adjusted models. Only patients with a
complete dataset were included in the regression analysis. Residuals
were tested for homoscedasticity, linearity and independence.
Other than when light and total PA were simultaneously used as inde-
pendent variables, the variance inflation factor never exceeded five, in-
dicating that multi-collinearity was not a concern (Montgomery et al.,
2012). The data were analysed using SPSS Statistics for Windows,
Version 22.0 (Armonk, NY: IBM Corp), with statistical significance set
at p-value b 0.05. Statistical comparisons between the two psychiatricphysical activity, cardiorespiratory fitness and cardiometabolic risk in
g/10.1016/j.schres.2017.10.012
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disorders (n = 11) data could have led to type II statistical errors.
3. Results
Forty-three patients with psychosis were included in the analysis,
and characteristics are summarized in Table 1. Within the sample, 28
patients (65.2%) met the criteria for metabolic syndrome. Those with
metabolic syndrome were significantly more sedentary, less physically
active (for all PA variables), and had lower CRF than those withoutmet-
abolic syndrome (all p b 0.05; data not shown). As presented in Table 2,
the high SB, low PA (all variables) and CRF groups exhibited a higher
presence ofmetabolic syndrome and number of cardiometabolic abnor-
malities than their counterparts, yet not reaching statistical significance
except when comparing light PA levels (both p b 0.05). Furthermore,
worse values and a higher presence of abnormalities for all individual-
cardiometabolic risk factors were found in the high SB and low lightTable 1
Patients' characteristics (n = 43).
Variables Values
Age (years) 42.3 ± 8.5
Body mass index (kg/m2) 30.5 ± 5.5
SB (h/day, % of waking time) 8.8 ± 2.1 (59)
LPA (h/day, % of waking time) 4.3 ± 1.6 (28)
MVPA (h/day, % of waking time) 1.9 ± 1.2 (13)
TPA (h/day, % of waking time) 6.2 ± 2.3 (41)
CRF (m) 598.7 ± 94.6
MetSa 28 (65.1)
No. of meeting MetSa 2.8 ± 1.7
Waist (cm) 105.6 ± 16.5
IDF criteria 36 (83.7)
SBP (mm Hg) 126.3 ± 17.8
IDF criteria 21 (48.8)
DBP (mm Hg) 82.4 ± 11.0
IDF criteria 20 (46.5)
TG (mg/dL) 210.5 ± 177.0
IDF criteria 25 (58.1)
HDL-C (mg/dL) 44.4 ± 11.8
IDF criteria 21 (48.8)
FBG (mg/dL) 106.9 ± 38.8
IDF criteria 20 (46.5)
Severity of psychiatric symptoms (0–72)b, c 14.7 ± 11.6
Illness duration (years)b 16.2 ± 9.3
Chlorpromazine equivalent dose (mg/day)b 643.7 ± 576.2
Smoking status (current smoker) 25 (58.1)
Gender (women) 6 (14.0)
Race (Caucasian) 43 (100)
Diagnoses
Schizophrenia spectrum disorders 32 (74.4)






Unfinished secondary school 20 (47.6)





Note: Values are in mean ± SD or n (%). SB, LPA, MVPA, and TPA are for an average day.
CRF: cardiorespiratory fitness; DBP: diastolic blood pressure; FBG: fasting blood glucose;
HDL-C: high-density lipoprotein cholesterol; IDF: International Diabetes Federation;
LPA: light physical activity; MetS: metabolic syndrome; MVPA: moderate-to-vigorous
physical activity; SB: sedentary behaviour; SBP: systolic blood pressure; TG: triglycerides;
TPA: total physical activity, Waist: waist circumference.
a According to the International Diabetes Federation criteria.
b Missing data. Reasons: Incomplete patientmedical recorddata for illness duration and
chlorpromazine equivalent dose (n = 1 and 3, respectively); incomplete questionnaire
data for severity of psychiatric symptoms, educational and occupational status (all n=1).
c Severity of psychiatric symptoms was assessed using the Brief Symptoms Inventory-
18; with higher scores indicating high severity of psychiatric symptoms.
Please cite this article as: Bueno-Antequera, J., et al., Sedentary behaviour,
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counterparts; however, significance was only indicated in diastolic
blood pressure between SB levels and in waist and triglycerides be-
tween light PA levels (all p b 0.05). The low total PA group had a signif-
icantly higher waist than the high total PA group (p = 0.025).
Additionally, a heightened CCRS was found in the high SB, and low PA
(all variables) and CRF groups, albeit significant only when comparing
light and total PA levels (both p b 0.05; data not shown).
Correlations between SB, PA, CRF, and cardiometabolic risk are pre-
sented in Table 3. SB had a significant negative correlation with all PA
variables and CRF (all p b 0.05). Furthermore, moderate-to-vigorous
and total PA had a significant moderate positive correlation with CRF
(both p b 0.05). The CCRS and the number of cardiometabolic abnormal-
ities were positively associated with SB and negatively associated with
light PA, total PA, and CRF (all p b 0.05). In general, significant correla-
tionswith individual-cardiometabolic risk factorswere fair tomoderate,
ranging from 0.30 to 0.57, expressed in absolute terms (Table 3).
Due tomissing data, a subsample of 38 patients (32men and 11with
bipolar disorders) with no changes in the correlation coefficients of the
significant correlates (all p b 0.05; data not shown) was included in the
multiple regression analysis (Table 4). SB was associated with the
CCRS (β= 0.28, p = 0.049), the number of cardiometabolic abnormal-
ities (β = 0.33, p = 0.023), waist (β = 0.45, p = 0.001), and fasting
blood glucose (β = 0.38, p = 0.023) (Model-1). The associations with
the CCRS and the number of cardiometabolic abnormalities became
non-significant after adjustment for the combined PA and CRF. A signif-
icant association for waist remained after adjusting for moderate-to-
vigorous PA and CRF. Furthermore, the association with fasting blood
glucose remained significant after adjusting for all PA variables,
in separate fully adjusted models, and for CRF. Light PA was
associated with waist (β=0.40, p= 0.005) (Model-1). The association
attenuated to non-significance after adjusting for SB, moderate-to-
vigorous PA, and CRF. Moderate-to-vigorous PA was associated with
the CCRS (β = −0.30, p = 0.043) (Model-1). The association moved
beyond the threshold of significance after adjusting for SB, PA
(light and total PA, in separate fully adjusted models), and CRF. Total
PA was associated with the CCRS (β = −0.32, p = 0.024) and waist
(β = −0.38, p = 0.008) (Model-1). These results became non-
significant after adjust for SB, moderate-to-vigorous PA, and CRF. CRF
was significantly associated with the CCRS (β = −0.42, p = 0.026)
(Model 2), waist (β = −0.55, p = 0.001), and systolic blood pressure
(β = −0.45, p = 0.028) (Model-1). The associations with the CCRS
and waist remained after adjusting for SB and all PA variables (in sepa-
rate fully adjusted models) (Table 4).
4. Discussion
This is one of the few studies (Ekblom et al., 2015; Greer et al., 2015;
Knaeps et al., 2016a; Knaeps et al., 2016b; Shuval et al., 2014; van der
Velde et al., 2015) to evaluate the independent associations of SB, PA,
and CRF with cardiometabolic risk, and the first to focus on patients
with psychosis. The main result suggests that although high levels of
SB and low levels of PA and CRF are associated with a higher
clustered-cardiometabolic risk, only CRF remains significantly related
independent of multiple confounders (including SB and PA). Addition-
ally,when examining independently the single cardiometabolic risk fac-
tors, CRF and SB are associated with waist and SB with fasting blood
glucose, and all of these associations are independent of the other po-
tential exposures. Taken together, these results suggest the importance
of considering CRF and SB, regardless of PA, in the prevention and treat-
ment of metabolic disorders among patients with psychosis.
Our results showed the independent association between CRF and
clustered-cardiometabolic risk consistent with aforementioned similar
studies (Ekblom et al., 2015; Greer et al., 2015; Knaeps et al., 2016a;
Knaeps et al., 2016b; Shuval et al., 2014; van der Velde et al., 2015), in-
cluding three (Ekblom et al., 2015; Knaeps et al., 2016b; van der Veldephysical activity, cardiorespiratory fitness and cardiometabolic risk in
g/10.1016/j.schres.2017.10.012
Table 2
Comparison of cardiometabolic characteristics between levels of ST, PA, and CRF among outpatients with psychosis (n = 43).





















MetSa 16 (76.2) 12 (54.5) 17 (81.0) 11 (50.0) 15 (71.4) 13 (59.1) 16 (76.2) 12 (54.5) 16 (76.2) 12 (54.5)
No. of meeting MetSa 3.3 ± 1.7 2.4 ± 1.7 3.4 ± 1.4 2.3 ± 1.8 3.2 ± 1.7 2.5 ± 1.7 3.1 ± 1.7 2.5 ± 1.8 3.2 ± 1.7 2.5 ± 1.7
Waist (cm) 110.3 ± 18.0 101.2 ± 14.0 113.2 ± 12.6 98.4 ± 16.8 106.4 ± 17.6 104.8 ± 15.8 111.3 ± 15.2 100.1 ± 16.2 109.4 ± 18.5 102.0 ± 13.8
IDF-criteria 19 (90.5) 17 (77.3) 21 (100.0) 15 (68.2) 19 (90.5) 17 (77.3) 20 (95.2) 16 (72.7) 19 (90.5) 17 (77.3)
SBP (mm Hg) 130.3 ± 18.0 122.5 ± 17.2 127.9 ± 17.7 124.8 ± 18.2 127.7 ± 19.5 125.0 ± 16.4 131.3 ± 17.7 121.5 ± 16.9 131.2 ± 17.6 121.6 ± 17.1
IDF-criteria 12 (57.1) 9 (40.9) 11 (52.4) 10 (45.5) 12 (57.1) 9 (40.9) 13 (61.9) 8 (36.4) 13 (61.9) 8 (36.4)
DBP (mm Hg) 85.8 ± 11.6 79.1 ± 9.6 83.7 ± 11.9 81.2 ± 10.3 83.8 ± 12.3 81.1 ± 9.7 85.7 ± 11.0 79.2 ± 10.3 85.2 ± 11.5 79.7 ± 10.1
IDF-criteria 13 (61.9) 7 (31.8) 9 (42.9) 11 (50.0) 12 (57.1) 8 (36.4) 11 (52.4) 9 (40.9) 11 (52.4) 9 (40.9)
TG (mg/dL) 231.3 ± 196.6 190.6 ± 158.1 215.4 ± 102.9 205.7 ± 228.6 233.5 ± 198.5 188.5 ± 155.3 208.7 ± 101.3 212.2 ± 230.0 209.7 ± 144.7 211.3 ± 206.7
IDF-criteria 15 (71.4) 10 (45.5) 16 (76.2) 9 (40.9) 15 (71.4) 10 (45.5) 15 (71.4) 10 (45.5) 15 (71.4) 10 (45.5)
HDL-C (mg/dL) 43.0 ± 12.8 45.7 ± 11.0 41.3 ± 9.9 47.3 ± 13.0 44.2 ± 13.7 44.6 ± 10.1 42.4 ± 12.1 46.3 ± 11.6 43.7 ± 11.7 45.1 ± 12.2
IDF-criteria 10 (47.6) 11 (50.0) 11 (52.4) 10 (45.5) 11 (52.4) 10 (45.5) 11 (52.4) 10 (45.5) 11 (52.4) 10 (45.5)
FBG (mg/dL) 117.0 ± 51.2 97.2 ± 17.8 110.7 ± 527.2 103.2 ± 38.1 113.9 ± 51.7 100.2 ± 19.4 106.7 ± 40.8 107.0 ± 37.9 112.4 ± 41.9 101.5 ± 35.9
IDF-criteria 12 (57.1) 8 (36.4) 11 (52.4) 9 (40.9) 11 (52.4) 9 (40.9) 9 (42.9) 11 (50.0) 11 (52.4) 9 (40.9)
Notes: The sample was divided into low and high levels of SB, LPA, MVPA, TPA, and CRF using the median splits. Analyses were conducted with TG logarithmically transformed and FBG
reciprocally transformed to obtain a normal distribution, yet crude values are presented in the table for easier interpretation. Values are inmean± SD or n (%). SB, LPA,MVPA, and TPA are
for an average day.
CRF: cardiorespiratory fitness; DBP: diastolic blood pressure; FBG: fasting blood glucose; HDL\\C: high-density lipoprotein cholesterol; IDF: International Diabetes Federation; LPA: light
physical activity; MetS: metabolic syndrome; MVPA: moderate-to-vigorous physical activity; SB: sedentary behaviour; SBP: systolic blood pressure; TG: triglycerides; TPA: total physical
activity, Waist: waist circumference.
Boldface indicates statistical significance (p-value b 0.05).
a According to the International Diabetes Federation-criteria.
4 J. Bueno-Antequera et al. / Schizophrenia Research xxx (2017) xxx–xxxet al., 2015) that objectivelymeasured SB and PA and two (Knaeps et al.,
2016a; Knaeps et al., 2016b) that used a clustering of individual-
cardiometabolic risk factors in the same individual that might reflect
cardiometabolic risk even better than single independent risk factors,
as well as the number of cardiometabolic abnormalities and metabolic
syndrome (Wijndaele et al., 2006). Our results in patients with psycho-
sis indicated that, together with the lack of association of SB and PA, CRF
is the most important exposure for cardiometabolic risk, concurring
with the findings of the two studies that used the CCRS (Knaeps et al.,
2016a; Knaeps et al., 2016b). An explanation may be because CRF re-
flects both participation in sedentary and physical activities and the
state of physiological systems, thereby providing more information
about health status. Moreover, each 5-mL·kg−1·min−1 decrement in
peak oxygen uptake (the criterion measure of CRF) corresponds to
56% higher prevalence of cardiovascular risk factors (Aspenes et al.,
2011), being a deficient CRF one of the main cardiovascular mortality
risk factors (Harber et al., 2017). These findings are of clinical interest,
and, consistent with strongly supported evidence (Ross et al., 2016),Table 3
Pearson correlation coefficients (r) for the association between SB, PA, CRF, and cardiometabol
SB LPA
r p-Value r p-Value
CCRS 0.43 0.004 −0.45 0.002
No. of meeting MetSa 0.38 0.012 −0.41 0.006
Waist 0.51 0.001 −0.57 b0.001
SBP 0.34 0.026 −0.25 0.101
DBP 0.34 0.026 −0.28 0.066
TG −0.18 0.258 0.24 0.123
HDL-C 0.20 0.203 −0.20 0.188
FBG 0.39 0.010 −0.10 0.522
SB 1.00 – −0.60 b0.001
LPA −0.60 b0.001 1.00 –
MVPA −0.55 b0.001 0.45 0.003
TPA −0.67 b0.001 0.88 b0.001
CRF −0.37 0.014 0.24 0.126
Notes: Analyses were conducted with MVPA and TG logarithmically transformed, and FBG rec
CCRS: clustered-cardiometabolic risk score; CRF: cardiorespiratory fitness; DBP: diastolic blood
activity; MetS: metabolic syndrome; MVPA: moderate-to-vigorous physical activity; SB: seden
Waist: waist circumference.
Boldface indicates statistical significance (p-value b 0.05).
a According to the International Diabetes Federation-criteria (cita).
Please cite this article as: Bueno-Antequera, J., et al., Sedentary behaviour,
psychosis: The PsychiActive project, Schizophr. Res. (2017), https://doi.orhighlight that CRF must be considered as a vital sign in clinical practice
and in public health.
No study has accounted for SB, PA, and CRF simultaneously in pa-
tients with psychosis, and consequently, our results can be compared
only with studies including two of the three exposures. Consistent
findings in patients with psychosis reported that only CRF, and not PA,
was significantly correlated with clustered-cardiometabolic risk
(metabolic syndrome) (Nyboe et al., 2015). In another study (Stubbs
et al., 2015), it was found that SB, and not PA, was associated with
high-sensitivity C-reactive protein level, an inflammatory-marker asso-
ciated with metabolic syndrome (Kazemi-Bajestani et al., 2017). Al-
though similar findings, the two aforementioned studies (Nyboe et al.,
2015; Stubbs et al., 2015) were based on self-reported measures of SB
and PA, and consequently, direct comparisons with our results may
not be valid. Therefore, in addition to examining the relationship of
SB, PA and CRF together for predicting clustered-cardiometabolic risk,
our work contributes to the knowledge by objectively measuring
behaviour.ic risk among outpatients with psychosis (n = 43).
MVPA TPA CRF
r p-Value r p-Value r p-Value
−0.27 0.084 −0.39 0.009 −0.45 0.003
−0.23 0.130 −0.40 0.004 −0.35 0.021
−0.25 0.111 −0.47 b0.001 −0.34 0.025
−0.17 0.280 −0.24 0.060 −0.38 0.012
−0.08 0.618 −0.24 0.061 −0.25 0.099
0.17 0.277 0.25 0.051 0.17 0.270
−0.21 0.182 −0.30 0.025 −0.26 0.088
0.06 0.722 −0.24 0.120 −0.07 0.677
−0.55 b0.001 −0.67 b0.001 −0.37 0.014
0.45 0.003 0.88 b0.001 0.24 0.126
1.00 – 0.78 b0.001 0.53 b0.001
0.78 b0.001 1.00 – 0.47 0.001
0.53 b0.001 0.47 b0.001 1.00 –
iprocally transformed, to obtain a normal distribution.
pressure; FBG: fasting blood glucose; HDL-C: high-density lipoprotein; LPA: light physical
tary behaviour; SBP: systolic blood pressure; TG: triglycerides; TPA: total physical activity,
physical activity, cardiorespiratory fitness and cardiometabolic risk in
g/10.1016/j.schres.2017.10.012
Table 4
Standardized regression coefficients (β) of SB, PA, and CRF for cardiometabolic risk among patients with psychosis (n = 38).
CCRS No. of meeting
MetSa
Waist (cm) SBP (mm Hg) DBP (mm Hg) TG (mg/dL) HDL-C (mg/dL) FBG (mg/dL)
β p-Value β p-Value β p-Value β p-Value β p-Value β p-Value β p-Value β p-Value
SB M1 0.28 0.049 0.33 0.023 0.45 0.001 0.26 0.128 0.29 0.090 0.20 0.198 −0.16 0.297 0.38 0.023
M2 0.01 0.967 −0.01 0.945 0.24 0.202 −0.09 0.642 0.44 0.032
M2 + LPA 0.34 0.042 0.29 0.108 0.34 0.038 0.01 0.960 −0.01 0.979 0.30 0.159 −0.11 0.595 0.59 0.010
M2 + MVPA 0.22 0.104 0.35 0.072 0.48 0.007 0.01 0.953 0.06 0.805 0.16 0.495 0.05 0.824 0.77 0.002
M2 + TPA 0.30 0.099 0.31 0.128 0.38 0.040 0.04 0.864 0.01 0.966 0.20 0.397 −0.02 0.921 0.71 0.005
M2 + CRF 0.19 0.124 0.28 0.086 0.31 0.026 −0.04 0.848 −0.02 0.895 0.21 0.278 −0.04 0.845 0.43 0.045
M2 + LPA + CRF 0.22 0.179 0.26 0.189 0.22 0.161 −0.03 0.888 −0.02 0.936 0.28 0.212 −0.07 0.757 0.58 0.015
M2 + MVPA + CRF 0.19 0.147 0.32 0.107 0.40 0.016 0.02 0.938 0.06 0.801 0.16 0.498 0.05 0.836 0.77 0.002
M2 + TPA + CRF 0.24 0.166 0.29 0.164 0.32 0.069 0.04 0.880 0.01 0.971 0.20 0.409 −0.02 0.935 0.71 0.005
LPA M1 −0.26 0.063 −0.24 0.109 −0.40 0.005 −0.22 0.197 −0.25 0.150 −0.03 0.836 0.09 0.585 −0.03 0.851
M2 0.00 0.994 0.02 0.922 0.00 0.983 −0.01 0.977 0.05 0.797
M2 + SB −0.05 0.758 −0.06 0.745 −0.19 0.230 0.01 0.976 0.01 0.942 0.13 0.517 −0.06 0.784 0.32 0.134
M2 + MVPA −0.15 0.381 −0.18 0.316 −0.36 0.035 0.00 0.998 −0.03 0.886 0.14 0.498 −0.13 0.513 0.02 0.933
M2 + CRF −0.12 0.356 −0.18 0.268 −0.27 0.045 0.03 0.888 0.02 0.895 0.02 0.920 −0.03 0.849 0.07 0.722
M2 + SB + MVPA + CRF −0.03 0.867 −0.07 0.718 0.25 0.163 −0.02 0.940 −0.03 0.897 0.18 0.420 −0.12 0.590 0.17 0.423
MVPA M1 −0.30 0.043 −0.21 0.178 −0.29 0.061 −0.16 0.379 −0.13 0.497 −0.21 0.200 0.23 0.161 0.01 0.954
M2 0.00 0.991 0.07 0.657 −0.21 0.229 0.18 0.287 0.07 0.713
M2 + LPA −0.21 0.242 −0.10 0.599 −0.07 0.689 0.00 0.994 0.09 0.654 −0.28 0.174 0.20 0.442 0.06 0.792
M2 + SB −0.25 0.093 0.03 0.873 0.05 0.776 0.01 0.965 0.11 0.620 −0.12 0.588 0.21 0.334 0.51 0.023
M2 + TPA −0.08 0.762 0.01 0.980 0.12 0.644 −0.06 0.845 0.14 0.615 −0.21 0.491 0.25 0.217 0.15 0.669
M2 + CRF −0.10 0.536 −0.12 0.529 −0.06 0.717 0.09 0.654 0.11 0.549 −0.18 0.362 0.12 0.518 0.16 0.468
M2 + SB + LPA + CRF 0.07 0.722 0.10 0.660 0.25 0.163 0.10 0.690 0.16 0.534 −0.15 0.550 0.31 0.239 0.54 0.033
M2 + SB + TPA + CRF 0.07 0.761 0.12 0.677 0.30 0.197 0.02 0.943 0.19 0.550 −0.12 0.704 0.26 0.403 0.48 0.122
TPA M1 −0.32 0.024 −0.25 0.097 −0.38 0.008 −0.19 0.277 −0.23 0.197 −0.17 0.290 0.17 0.268 −0.05 0.784
M2 0.03 0.872 0.03 0.863 −0.18 0.329 0.11 0.524 0.03 0.898
M2 + SB −0.10 0.586 −0.03 0.888 −0.11 0.545 0.05 0.819 0.04 0.872 −0.06 0.791 0.10 0.660 0.44 0.057
M2 + MVPA −0.26 0.295 −0.26 0.342 −0.48 0.061 0.08 0.802 −0.09 0.761 −0.01 0.980 −0.11 0.720 −0.09 0.788
M2 + CRF −0.13 0.389 −0.17 0.332 −0.19 0.214 0.11 0.576 0.05 0.775 −0.13 0.609 0.04 0.823 0.09 0.671
M2 + SB + MVPA + CRF −0.09 0.700 −0.06 0.821 −0.18 0.436 0.11 0.724 −0.06 0.839 0.06 0.860 −0.12 0.715 0.19 0.534
CRF M1 −0.42 0.026 −0.29 0.118 −0.55 0.001 −0.45 0.028 −0.40 0.058 −0.18 0.350 0.30 0.113 −0.22 0.296
M2 −0.21 0.359 −0.05 0.807 −0.20 0.393 0.25 0.265 −0.18 0.492
M2 + SB −0.46 0.005 −0.12 0.553 −0.37 0.034 −0.22 0.357 −0.06 0.791 −0.13 0.575 0.24 0.311 −0.05 0.850
M2 + LPA −0.45 0.010 −0.21 0.293 −0.43 0.011 −0.21 0.362 −0.06 0.798 −0.20 0.399 0.26 0.267 −0.19 0.472
M2 + MVPA −0.45 0.018 −0.22 0.317 −0.52 0.009 −0.26 0.314 −0.12 0.634 −0.10 0.708 0.18 0.470 −0.27 0.355
M2 + TPA −0.42 0.026 −0.17 0.423 −0.43 0.026 −0.26 0.294 −0.08 0.740 −0.13 0.609 0.23 0.355 −0.23 0.431
M2 + SB + LPA −0.37 0.039 −0.11 0.583 −0.35 0.045 −0.22 0.366 −0.06 0.793 −0.14 0.565 0.24 0.315 −0.06 0.808
M2 + SB + MVPA −0.42 0.026 −0.14 0.505 −0.42 0.021 −0.26 0.323 −0.12 0.637 −0.10 0.701 0.18 0.481 −0.29 0.250
M2 + SB + TPA −0.38 0.043 −0.12 0.570 −0.37 0.046 −0.26 0.305 −0.08 0.745 −0.13 0.622 0.23 0.365 −0.21 0.400
Notes:M1 is adjusted for gender, age, smoking, education, severity of psychiatric symptoms, illness duration, and chlorpromazinedose.M2 is adjusted for all covariates inM1 and adjusted
for waist circumference (except when CCRS, No. of meetingMetS andWaist were the outcomes). Analyses were conducted with MVPA and TG logarithmically-transformed, and FBG re-
ciprocally-transformed, to obtain a normal distribution.
CCRS: clustered-cardiometabolic risk score; CRF: cardiorespiratory fitness; DBP: diastolic blood pressure; FBG: fasting blood glucose; HDL-C: high-density lipoprotein cholesterol; LPA:
light physical activity; M: model; MetS: metabolic syndrome; MVPA: moderate-to-vigorous physical activity; SB: sedentary behaviour; SBP: systolic blood pressure; TG: triglycerides;
TPA: total physical activity, Waist: waist circumference.
Boldface indicates statistical significance (p-value b 0.05).
a According to the International Diabetes Federation-criteria.
5J. Bueno-Antequera et al. / Schizophrenia Research xxx (2017) xxx–xxxOur results indicated that CRF and SB are both related to waist,
independent from each other and from PA, suggesting that CRF and SB
are two independent predictors of waist. Consistent findings in patients
with psychosis have revealed significant associations between CRF
and waist accounting for self-reported PA (Nyboe et al., 2015;
Vancampfort et al., 2015a). However, our results were inconsistent
with the findings of the only study in patients with psychosis that ex-
plored the SB-waist association adjusting for PA (Stubbs et al., 2017).
This discrepancy may be because the authors of that study (Stubbs
et al., 2017) used accelerometers to obtain an objective indirect estima-
tions of SB and PA through the absence of whole-body movement and
the number of steps, respectively, which could introduce bias for both
exposures. Considering SB as the absence of whole-body movement is
an important conceptual error (Sedentary Behaviour Research, 2012),
and the number of steps only provides a value of total ambulatory PA,
thereby excluding a range of free-living physical activities aside from
walking and or running, such as gardening or washing, which have
shown beneficial effects on cardiovascular health (van den Berg et al.,
2010). Accordingly, the use of sensor combining physiological measures
with movement and position sensing to identify SB and PA may be a
more appropriate way to obtain accurate results.Please cite this article as: Bueno-Antequera, J., et al., Sedentary behaviour,
psychosis: The PsychiActive project, Schizophr. Res. (2017), https://doi.orAgain, inconsistent with the aforementioned study (Stubbs et al.,
2017), our results showed that the relationship between SB and fasting
blood glucose remained significant when adjusting for PA. Discrepan-
cies between studies can be explained, in addition to the different in-
struments of assessment of SB and PA used, because we assessed PA at
different intensities and controlled for waist, a predisposing factor for
the development of type 2 diabetes mellitus (Freemantle et al., 2008),
showing that the SB-fasting blood glucose association did not vary. Ad-
ditionally, our findings remained significant evenwhen CRFwas includ-
ed with the rest of the confounders, suggesting that SB seems to be an
important and independent risk factor for fasting blood glucose in pa-
tients with psychosis. However, further research combining SB, PA,
and CRF interactions with cardiometabolic outcomes in patients with
psychosis is needed before any firm conclusions can be made.
The major strength of the study is the objective measurement of SB
and PA using strict inclusion criteria. All patients wore the SenseWear
for seven consecutive days with at least 1368 min/day, and the Haw-
thorne effect (explained in brief in themethod section)wasminimized.
Another strength is the use of the time spent in different intensities of
PA which extends the knowledge on the independent association of
SB, PA, and CRFwith cardiometabolic risk and informs, in greater detail,physical activity, cardiorespiratory fitness and cardiometabolic risk in
g/10.1016/j.schres.2017.10.012
6 J. Bueno-Antequera et al. / Schizophrenia Research xxx (2017) xxx–xxxon intervention strategies for treating metabolic disorders among pa-
tients with psychosis focused on the development of a more active life-
style that enhance/maintain CRF. Finally, the adjustment for covariates
that could influence the relationships between SB, PA, and CRFwith car-
diometabolic risk can also be considered a strength. Multiple linear re-
gression analyses were adjusted for obesity in addition to other
covariates such as gender, age, smoking, education, symptom severity,
illness duration, and antipsychotic medication, previously controlled
in psychiatric patients studies (i.e., Stubbs et al., 2017). This approach
was only applied in two (Shuval et al., 2014; van der Velde et al.,
2015) of the six studies (Ekblom et al., 2015; Greer et al., 2015;
Knaeps et al., 2016a; Knaeps et al., 2016b; Shuval et al., 2014; van der
Velde et al., 2015) that evaluated the independent associations of SB,
PA, and CRF with cardiometabolic risk.
Some limitations should be noted. The small sample size of outpa-
tients, predominantly men diagnosed with schizophrenia, may limit
the generalization to other groups. Future research should use large
and homogeneous sample, and compare between different clinical set-
tings, genders, and psychiatric disorders. Another limitation is that the
current study was cross-sectional in design. Longitudinal studies are
needed to identify any casual relationships. Although the absence of
control group can be considered a study limitation, we compared our
data against all published studies that have examined the independent
associations of SB, PA, and CRFwith cardiometabolic risk, each of which
is based on observations from hundreds of healthy individuals. Never-
theless, further studies including control group are required to confirm
or refute our findings. The SenseWear cannot differentiate body posi-
tions, and consequently, standing may be considered as SB. However,
it may solve limitations presented by accelerometers and inclinometers
through heat production measurements and placement on the upper
arm. Additionally, the SenseWear underestimates energy expenditure
at higher PA intensities (Drenowatz and Eisenmann, 2011). However,
becausewe used time engaged inmoderate-to-vigorous PA, it is unlike-
ly that this affected our results. Moreover, because the objective mea-
surement did not inform about the type of SB and PA, future studies
should combine objective with self-report measurements. In patients
with severe mental illness, the Sedentary Behaviour and the Interna-
tional Physical Activity questionnaires seem appropriate for quantifying
time engaged in different SBs (Bueno-Antequera et al., 2017) and PAs
(Faulkner et al., 2006), respectively. The assessment of CRF using an in-
direct measurement and a submaximal test could be considered as an-
other limitation. However, the test used in this study has been found
to be a reliable and valid method in patients with psychosis (Gomes
et al., 2016). The CCRS has several advantages for evaluating cardiomet-
abolic risk (Wijndaele et al., 2006), is sample-specific and is based on
the assumption that each component is weighted equally in predicting
cardiometabolic risk. Finally, dietary information was not considered
as a covariate, and the data on symptomatology was self-reported.
In conclusion, low CRFwas found to be a predictor of high clustered-
cardiometabolic risk independent ofmultiple confounders, including SB
and PA, in patients with psychosis. This study further found associations
of SB, PA, and CRF with individual-cardiometabolic risk factors. There-
fore, in addition to developing interventions to reduce SB and increase
PA, interventions of randomized controlled trials of physical exercise
in patients with psychosis are needed to determine whether reduced
CRF and increased cardiometabolic risk can be improved.
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